Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study to Establish Incidence and Characteristics of Patients at Risk for Symptomatic Hyperammonemia Secondary to Recombinant Erwinia Asparaginase

NCT06600659 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT06600659
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06600659 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study to Establish Incidence and Characteristics of Patients at Risk for Symptomatic Hyperammonemia Secondary to Recombinant Erwinia Asparaginase
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Recruiting
Start date
November 2, 2023
Completion date
December 1, 2026
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphobkastic leukemia, hematopoietic and lymphatic system neoplasm